Abstract

AimsGestational diabetes mellitus (GDM) is a prevalent and potentially serious condition which may put both mothers and neonates at risk. The current recommendation for diagnosis is the oral glucose tolerance test (OGTT). This study aimed to determine the usefulness of HbA1c test as a diagnostic tool for GDM as compared to the traditional criteria based on the OGTT.MethodsThis was a diagnostic test accuracy study. We performed OGTT and HbA1c test in women attending prenatal visits at a tertiary hospital. GDM was defined according to WHO1999 or ADA/WHO 2013 criteria. ROC curve was used to evaluate the diagnostic performance of HbA1c. Sensitivity, specificity and likelihood ratios for different HbA1c cut-off points were calculated.ResultsOf the 262 women in the third trimester of gestation enrolled in the study, 86 (33%) were diagnosed with GDM. Only five of these women presented HbA1c ≥48 mmol/mol (6.5%). This cut-off point presented 100% specificity but very low sensitivity (7%). Based on ROC curve, and considering OGTT as the reference criterion, HbA1c ≥40 mmol/mol (5.8%) showed adequate specificity in diagnosing GDM (94.9%) but low sensitivity (26.4%). Unlike, HbA1c values of 31 mmol/mol (5.0%) presented adequate sensitivity (89.7%) but low specificity (32.6%) to detect GDM. For women with HbA1c ≥40 mmol/mol (5.8%), the positive and negative likelihood ratios were 5.14 (95%CI 2.49–10.63) and 0.78 (0.68–0.88), respectively. The post-test probability of GDM was about 40%, representing a 4.0-fold increase in the mean pre-test probability. This cut-off point could eliminate the need for the unpleasant and laborious OGTT tests in almost one third of cases, as 38% of patients with GDM may be diagnosable by HbA1c test alone.ConclusionsOur results show that combined HbA1c and OGTT measurements may be useful in diagnosing GDM.

Highlights

  • Gestational diabetes mellitus (GDM) is a prevalent and potentially serious condition that may lead to adverse effects in both mothers and neonates [1]

  • The post-test probability of GDM was about 40%, representing a 4.0-fold increase in the mean pre-test probability. This cut-off point could eliminate the need for the unpleasant and laborious oral glucose tolerance test (OGTT) tests in almost one third of cases, as 38% of patients with GDM may be diagnosable by HbA1c test alone

  • Our results show that combined HbA1c and OGTT measurements may be useful in diagnosing GDM

Read more

Summary

Introduction

Gestational diabetes mellitus (GDM) is a prevalent and potentially serious condition that may lead to adverse effects in both mothers and neonates [1]. It is associated with preeclampsia, increased caesarean rates, and macrosomia [2, 3]. The detection and treatment of this condition reduce the risks for the mothers as well as for the babies [4,5]. The OGTT has been the test of choice for this condition. It can be preceded by a screening strategy such as fasting glycemia (FG) or a glucose load test. There are still divergences as to the OGTT cut-offs which should be used for the diagnosis of GDM and a recent review concluded that the evidence are insufficient to permit assessment of which strategy is best to diagnose GDM [7, 8]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call